Parkinson Disease (PD) is a common chronic degenerative disease of the central nervous system, with resting tremor, increased muscle tone, motor retardation, and postural reflex disorders as the main clinical manifestations. According to statistics, the incidence of PD increases with age. With the accelerated aging process in China, the incidence of PD has a tendency to increase year by year, and because of the progressive aggravation of PD, half of the patients cannot take care of themselves after 5-8 years, causing a heavy economic burden to their families and society. At present, the common clinical treatment for Parkinson’s disease is still based on alternative therapies. These include: Western medicine, surgery and Chinese medicine. The advantage of Western medicine in the treatment of Parkinson’s disease is that it is more targeted and can rapidly control clinical symptoms, but its shortcoming is that the toxic side effects of drugs are so great that many patients are forced to stop taking them because they cannot tolerate them. Many toxic side effects are the inevitable result of the increasing dosage of Western medicine. Even the “golden drug” for Parkinson’s, Methotrexate, is recognized for its efficacy, but its efficacy decreases with prolonged use, and there are cases of nausea, vomiting, abdominal pain, constipation, dizziness, and arrhythmia, forcing many patients to discontinue the drug because they cannot tolerate it. Moreover, side effects such as switching phenomenon and drug tolerance phenomenon can occur, which prompted people to find new ways to treat PD. In recent years, a large number of studies have shown that Chinese medicine has the advantages of significant efficacy and low toxic side effects in the treatment of Parkinson’s disease. With 30 years of clinical experience, I have developed a pure Chinese medicine preparation for the treatment of Parkinson’s disease —-, which has been clinically proven to improve clinical efficacy, reduce the dosage of methadopa and alleviate the adverse effects of methadopa, in accordance with the pathogenesis of PD and the pathogenesis of liver and kidney yin deficiency. Especially for early stage patients, it is more effective. Patients can reduce the symptoms without western medicine by taking Ziyuanping Fibrillation Pill alone. In the middle and late stage patients, the combination of Chinese and Western drugs can improve the efficacy, slow down the increase of the dosage of Western drugs and reduce the adverse reactions. Therefore, I believe that the combined treatment of Parkinson’s disease with Chinese and Western medicine can give full play to the respective strengths of Chinese and Western medicine and achieve the purpose of complementary advantages, which is more conducive to the control of PD symptoms.